Slide 1Sarah Burke, Andrew Krasley, Maria Winters Hepatitis C Virus (HCV): Serine Protease Inhibitors Slide 2 Some Statistics  3% of the world population and 1.3% of the…

Slide 1 COMMON HEPATIC DISORDERS: points for health education DR. Ahmed Zeid HPBU. Alexandria university Slide 2 Acute and chronic hepatitis Slide 3 DEFINITION Acute hepatitis:…

Slide 1 Slide 2 HIV and Hepatitis Workshop Kathleen Clanon, MD [email protected] 8/06 Slide 3 Treatment of HCV in Coinfected Patients Slide 4 Why Do We Need to Treat HIV/HCV…

Expanding the Universe of Viral Hepatitis Treaters Screening High Risk Patients for HBV Missed Opportunities for HBV Vaccination in the US Primary Care Physiciansâ Attitudes…

HIV and Hepatitis C Co-infection: Current Standards and New Paradigms Todd S. Wills, MD Associate Professor of Internal Medicine Division of Infectious Disease and International…

HIV and Hepatitis C Co-infection: Current Standards and New Paradigms Todd S. Wills, MD Associate Professor of Internal Medicine Division of Infectious Disease and International…

Perfil sociodemográfico, epidemiológico y clínico de pacientes adultos con infección por VIH según su edad Temporal Trends in Liver-Related Mortality in a…

Care of the Treatment-naive Patient With HCV/HIV Coinfection Care of the Treatment-naive Patient With HCV/HIV Coinfection Case 47-Year-Old Man With Asymptomatic HIV Infection…

Perfil sociodemográfico, epidemiológico y clínico de pacientes adultos con infección por VIH según su edad Temporal Trends in Liver-Related Mortality in a…

DAAâs in the treatment of HCV: The Beginning of the end or the end of the beginning for HCV? DAAâs in the treatment of HCV: The Beginning of the end or the end of the beginning…